These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 7204538

  • 1. Dopaminergic mechanisms and luteinizing hormone (LH) secretion. II. Differential effects of dopamine and bromocriptine on LH release in normal women.
    Martin WH, Rogol AD, Kaiser DL, Thorner MO.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):650-6. PubMed ID: 7204538
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic mechanisms and luteinizing hormone secretion. I. Acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyperprolactinemic women.
    Evans WS, Rogol AD, MacLeod RM, Thorner MO.
    J Clin Endocrinol Metab; 1980 Jan; 50(1):103-7. PubMed ID: 7188612
    [Abstract] [Full Text] [Related]

  • 3. [Effects of bromocriptine and dopamine on pituitary hormone secretion in women].
    Masaoka K, Hosoya N, Mori T, Watanabe H, Ohkura T, Kumasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2155-62. PubMed ID: 6818310
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A, Beitins IZ, Merriam GR, McArthur JW, Zervas NT, Ridgway EC.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [Abstract] [Full Text] [Related]

  • 6. Interaction between hypothalamic dopaminergic and opioidergic systems in the photoperiodic regulation of pulsatile luteinizing hormone secretion in sheep.
    Tortonese DJ.
    Endocrinology; 1999 Feb; 140(2):750-7. PubMed ID: 9927302
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary.
    Cheung CY.
    Endocrinology; 1983 Aug; 113(2):632-8. PubMed ID: 6347662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women.
    Pontiroli AE, Alberetto M, Pellicciotta G, De Castro e Silva E, De Pasqua A, Girardi AM, Pozza G.
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):271-6. PubMed ID: 7376792
    [Abstract] [Full Text] [Related]

  • 11. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.
    Kremer JA, Borm G, Schellekens LA, Thomas CM, Rolland R.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
    Falaschi P, Rocco A, del Pozo E.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):348-51. PubMed ID: 3510225
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperresponsiveness to the inhibitory action of dopamine agonists on luteinizing hormone secretion in the monosodium-L-glutamate-treated, orchidectomized rat.
    Rose PA, Weick RF.
    Neuroendocrinology; 1986 Feb; 44(1):95-101. PubMed ID: 3024058
    [Abstract] [Full Text] [Related]

  • 16. Further evidence that prolactin does not affect gonadotropin release at pituitary level.
    Hetzel WD, Schneider PM, Pfeiffer EF.
    Horm Metab Res; 1987 Nov; 19(11):555-62. PubMed ID: 3323020
    [Abstract] [Full Text] [Related]

  • 17. Hyperprolactinemia inhibits gonadotropin-releasing hormone (GnRH) stimulation of the number of pituitary GnRH receptors.
    Garcia A, Herbon L, Barkan A, Papavasiliou S, Marshall JC.
    Endocrinology; 1985 Sep; 117(3):954-9. PubMed ID: 2990879
    [Abstract] [Full Text] [Related]

  • 18. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
    Seki K, Kato K, Shima K.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
    [Abstract] [Full Text] [Related]

  • 19. The effects of ovariectomy and estrogen treatment on the dopamine inhibition of gonadotropin and prolactin release.
    Judd SJ, Rigg LA, Yen SS.
    J Clin Endocrinol Metab; 1979 Aug; 49(2):182-4. PubMed ID: 572372
    [Abstract] [Full Text] [Related]

  • 20. [Effects of bromocriptine on FSH and LH secretion in women with euprolactinemic anovulation (author's transl)].
    Mori H, Aisaka K, Kigawa T, Minakuchi H, Sakamoto S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1741-8. PubMed ID: 6796631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.